Literature DB >> 10650261

Endoscopic management of sump syndrome after choledochoduodenostomy: retrospective analysis of 30 cases.

F X Caroli-Bosc1, J F Demarquay, E P Peten, R Dumas, A Bourgeon, P Rampal, J P Delmont.   

Abstract

BACKGROUND: Side-to-side choledochoduodenostomy is a frequently performed operation. Postoperative biliary "sump syndrome" is infrequent, a complication for which endoscopic sphincterotomy is regarded as the treatment of choice.
METHODS: We retrospectively analyzed 30 cases of sump syndrome and describe the symptoms, the delay before the appearance of symptoms, laboratory abnormalities, the nature of the biliary obstruction, and the outcome of endoscopic sphincterotomy including its efficiency and complications.
RESULTS: The median clinical latency was 5 years (range 1 month to 28 years), the median delay between surgery and diagnosis was 6 years (range 1 month to 28 years). Fourteen patients had abdominal pain with fever, 5 had isolated abdominal pain, 4 had post-prandial pain, 4 had hepatic abscesses, and 3 had acute pancreatitis. Liver function tests were abnormal in 79%. During endoscopic retrograde cholangiopancreatography, food debris was identified in 18 patients in the biliary sump, biliary calculi in 10 patients, and a mixture of food and calculi in 2 patients. All patients underwent endoscopic sphincterotomy without complication. Recurrence during a median follow-up of 36 months (range 3 months to 11 years) was not observed.
CONCLUSIONS: Sump syndrome most often becomes symptomatic only after a long delay. Abdominal pain with fever was the most frequent symptom. Liver function tests were abnormal in the majority of patients. Food debris was the most frequent cause. Endoscopic sphincterotomy appeared to be a safe, reliable treatment.

Entities:  

Mesh:

Year:  2000        PMID: 10650261     DOI: 10.1016/s0016-5107(00)70415-9

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  13 in total

1.  Sump syndrome as a complication of choledochoduodenostomy.

Authors:  Motaz Qadan; Sharon Clarke; Ellen Morrow; George Triadafilopoulos; Brendan Visser
Journal:  Dig Dis Sci       Date:  2011-12-14       Impact factor: 3.199

Review 2.  Management of common bile duct stones.

Authors:  Eric S Hungness; Nathaniel J Soper
Journal:  J Gastrointest Surg       Date:  2006-04       Impact factor: 3.452

3.  Operative management of recurrent choledocholithiasis.

Authors:  Kazuhide Matsushima; David I Soybel
Journal:  J Gastrointest Surg       Date:  2012-08-21       Impact factor: 3.452

4.  Choledochoduodenostomy: is it really so bad?

Authors:  William McIver Leppard; Thomas Michael Shary; David B Adams; Katherine A Morgan
Journal:  J Gastrointest Surg       Date:  2011-02-24       Impact factor: 3.452

5.  Current assessment of choledochoduodenostomy: 130 consecutive series.

Authors:  H Okamoto; K Miura; J Itakura; H Fujii
Journal:  Ann R Coll Surg Engl       Date:  2017-09       Impact factor: 1.891

6.  Recurrent bile duct stones after transduodenal sphincteroplasty.

Authors:  S M G Kibria; R Hall
Journal:  HPB (Oxford)       Date:  2002       Impact factor: 3.647

7.  Open Choldecho-Enterostomy for Common Bile Duct Stones: Is it Out of Date in Laparo-Endoscopic Era?

Authors:  Khnissi Abdelmajid; Harbi Houssem; Ghrissi Rafik; Mohamed S Jarrar; Hamila Fehmi
Journal:  N Am J Med Sci       Date:  2013-04

8.  Hepaticojejunostomy for the management of sump syndrome arising from choledochoduodenostomy in a patient who underwent bariatric Roux-en-Y gastric bypass: A case report.

Authors:  Mohammed S Alqahtani; Shadi A Alshammary; Enas M Alqahtani; Shoukat A Bojal; Amal Alaidh; Gelu Osian
Journal:  Int J Surg Case Rep       Date:  2016-02-12

9.  Sump Syndrome: A Rare Long-Term Complication of Choledochoduodenostomy.

Authors:  Hrudya Abraham; Sajan Thomas; Amit Srivastava
Journal:  Case Rep Gastroenterol       Date:  2017-08-04

10.  Various techniques for the surgical treatment of common bile duct stones: a meta review.

Authors:  Abolfazl Shojaiefard; Majid Esmaeilzadeh; Ali Ghafouri; Arianeb Mehrabi
Journal:  Gastroenterol Res Pract       Date:  2009-08-06       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.